← Back to Search

N/A

Low-dose pain medication for Virtual Reality Therapy

N/A
Waitlist Available
Led By Samuel Sharar, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy male and females between the age of 18 and 60 years
Ability to communicate orally
Timeline
Screening 3 weeks
Treatment Varies
Follow Up conclusion of 120 study visits. each participant will spend a total of 8 hours with us.
Awards & highlights

Study Summary

The purpose of this study is to determine how pain relief is modified when the investigators combine the Virtual Reality based Snow World game with certain pain medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~conclusion of 120 study visits. each participant will spend a total of 8 hours with us.
This trial's timeline: 3 weeks for screening, Varies for treatment, and conclusion of 120 study visits. each participant will spend a total of 8 hours with us. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain responses between placebo and the low-dose pain medication while playing Snow World. We will assess pain responses with subjective questionnaires concerning the participant's experience while playing Snow World.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Low-dose pain medicationActive Control1 Intervention
80min IV infusion of a low-dose pain medication
Group II: saline placeboPlacebo Group1 Intervention
80min IV infusion of a saline placebo

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,726 Previous Clinical Trials
1,821,257 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,622 Total Patients Enrolled
Samuel Sharar, MDPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025